Literature DB >> 10201888

Cutting edge: LFA-1 is required for liver NK1.1+TCR alpha beta+ cell development: evidence that liver NK1.1+TCR alpha beta+ cells originate from multiple pathways.

T Ohteki1, C Maki, S Koyasu, T W Mak, P S Ohashi.   

Abstract

Using mice deficient for LFA-1, CD44, and ICAM-1, we examined the role of these adhesion molecules in NK1.1+TCR alpha beta+ (NKT) cell development. Although no defect in NKT cell development was observed in CD44-/- and ICAM-1-/- mice, a dramatic reduction of liver NKT cells was observed in LFA-1-/- mice. Normal numbers of NKT cells were present in other lymphoid organs in LFA-1-/- mice. When LFA-1-/- splenocytes were injected i.v. into wild-type mice, the frequency of NKT cells among donor-derived cells in the recipient liver was normal. In contrast, when LFA-1-/- bone marrow (BM) cells were injected i.v. into irradiated wild-type mice, the frequency of liver NKT cells was significantly lower than that of mice injected with wild-type BM cells. Collectively, these data indicate that LFA-1 is required for the development of liver NKT cells, rather than the migration to and/or subsequent establishment of mature NKT cells in the liver.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201888

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Immune recognition, response, and regulation: how T lymphocytes do it.

Authors:  S Joyce
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.

Authors:  Aleksandar K Stanic; Jang-June Park; Sebastian Joyce
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

Review 3.  Roles of liver innate immune cells in nonalcoholic fatty liver disease.

Authors:  Yu-Tao Zhan; Wei An
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

Review 4.  Raising the NKT cell family.

Authors:  Dale I Godfrey; Sanda Stankovic; Alan G Baxter
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

5.  Transcriptional regulator Id2 controls survival of hepatic NKT cells.

Authors:  Laurel A Monticelli; Yang Yang; Jamie Knell; Louise M D'Cruz; Michael A Cannarile; Isaac Engel; Mitchell Kronenberg; Ananda W Goldrath
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

6.  Up-regulation of LFA-1 allows liver-resident memory T cells to patrol and remain in the hepatic sinusoids.

Authors:  H A McNamara; Y Cai; M V Wagle; Y Sontani; C M Roots; L A Miosge; J H O'Connor; H J Sutton; V V Ganusov; W R Heath; P Bertolino; C G Goodnow; I A Parish; A Enders; I A Cockburn
Journal:  Sci Immunol       Date:  2017-03-17

7.  Neutrophilic granulocytes modulate invariant NKT cell function in mice and humans.

Authors:  Gerhard Wingender; Marcus Hiss; Isaac Engel; Konrad Peukert; Klaus Ley; Hermann Haller; Mitchell Kronenberg; Sibylle von Vietinghoff
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

8.  IL-15 regulates homeostasis and terminal maturation of NKT cells.

Authors:  Laura E Gordy; Jelena S Bezbradica; Andrew I Flyak; Charles T Spencer; Alexis Dunkle; Jingchun Sun; Aleksandar K Stanic; Mark R Boothby; You-Wen He; Zhongming Zhao; Luc Van Kaer; Sebastian Joyce
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

9.  Transcriptional control of invariant NKT cell development.

Authors:  Rupali Das; Derek B Sant'Angelo; Kim E Nichols
Journal:  Immunol Rev       Date:  2010-11       Impact factor: 12.988

10.  DOCK8 is critical for the survival and function of NKT cells.

Authors:  Greg Crawford; Anselm Enders; Uzi Gileadi; Sanda Stankovic; Qian Zhang; Teresa Lambe; Tanya L Crockford; Helen E Lockstone; Alexandra Freeman; Peter D Arkwright; Joanne M Smart; Cindy S Ma; Stuart G Tangye; Christopher C Goodnow; Vincenzo Cerundolo; Dale I Godfrey; Helen C Su; Katrina L Randall; Richard J Cornall
Journal:  Blood       Date:  2013-08-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.